物质信息

ID:578

名称和标识
IUPAC传统名
furosemide
IUPAC标准名
4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid
别名
FurosemideMetflorylthiazidineFurosemida [INN-Spanish]FursemidFrusemidMethforylthiazidineFrusemideDihydroflumethiazideFurosemidFurosemidu [Polish]Furosemidum [INN-Latin]FursemidaFursemide
商标名
AquaridAquasinBristurinCetasixDesalDi-AdemilUritolUrosemideVesixYidoliSalixSalurexSegurilSpirofurUresixUrianMacasiroolNelsixPromidePuresisRadisemideSalinexFuroterFuroviteFursolKutrixLasemidLasilixFuranturilFurixFurosemixTransitTrofuritUremideUrexUridonPromedesProtargenRadonnaRusydeSelectofurSynephronLogireneMyrosemideNadisNeo-RenalOdemasePrefeminHydro-RapidHydroledImpuganLasix RetardLazixLisideFuroreseFurosanFurosideFusidHydrenoxHydroZafimidaFuro-BasanFuromide M.D.Polysquall AProfeminRadounaRodiuranRosemideSaluridLowpstronLuscekMarsemideMirfatNovosemideOctan DraselnyKolkinLasexLasilettenLaxurLess DiurLowpstonFurosixGolanHissufluxHydolHydrexJenafusidFurosifarSal DiureticumSaluronSigasalurSisurilUrex-MVergonilOdemexOedemexOlmagranRetepRontylRosisFrusidFulsixLasix SpecialLeodrineMitaMoilarorinEdenolElodrineFluidrolFranylFrusedanFruseminDesdeminDiucardinDiurapidDiurinDiusemideEdemidLasixAldalixAldicAluzineBeronaldDepixFuro-PurenFurocotFuromenFurosedonKatlexKofuzonFlussFrumideFrumilFrusenexFureticFurmidBristabDirineDiuzolDranexDryptalErrolonFuranthrylFuresisFurfanAnfuramaideApo-FurosemideBioreticFurodiurolFurodrixFuromexFuroseFuluvamideFuranthrilFarsixFruseticFuluvamineFurantrilFurexFurobetaDiurolasaDurafuridEliurFrumexEutensinFrusemaDisemideDiuretic SaltDiusilEnduralDiuralFinuretDisalDiscoidDiumide-KAisemideApo-FrusemideArasemide
数据登录号
CAS号
PubChem CID
PubChem SID
化合物性质
理化性质
疏水性(logP)
1.4
溶解度
0.006 mg/mL
描述信息
Drug Groups
approved
Description
A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. [PubChem]
Indication
For the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Also for the treatment of hypertension alone or in combination with other antihypertensive agents.
Pharmacology
Furosemide, a sulfonamide-type loop diuretic structurally related to bumetanide, is used to manage hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome.
Toxicity
Profound diuresis may cause fluid and electrolyte depletion. Excessive dehydration and potassium depletion may occur. Excessive diuresis may cause rapid weight loss, orthostatic hypotension or acute hypotensive episodes. May also cause tinnitus, reversible or permanent hearing loss or reversible deafness.
Affected Organisms
Humans and other mammals
Biotransformation
Only a small amount is hepatically metabolized to the defurfurylated derivative, 4-chloro-5-sulfamoylanthranilic acid.
Absorption
60% absorbed in patients with normal renal function
Half Life
2 hours
Protein Binding
95% bound to plasma proteins
Elimination
Furosemide is excreted in urine. Significantly more furosemide is excreted in urine following the I.V. injection than after the tablet or oral solution.
References
• Rais-Bahrami K, Majd M, Veszelovszky E, Short BL: Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol. 2004 Aug;21(6):329-32. [Pubmed]
• Korpi ER, Kuner T, Seeburg PH, Luddens H: Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995 Feb;47(2):283-9. [Pubmed]
• Tia S, Wang JF, Kotchabhakdi N, Vicini S: Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABA(A) receptor alpha 6 subunit. J Neurosci. 1996 Jun 1;16(11):3630-40. [Pubmed]
• Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ: Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Mol Pharmacol. 1996 Sep;50(3):670-8. [Pubmed]
External Links
分子图谱
暂无数据
点击上传数据
参考文献
• Rais-Bahrami K, Majd M, Veszelovszky E, Short BL: Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol. 2004 Aug;21(6):329-32. Pubmed
• Tia S, Wang JF, Kotchabhakdi N, Vicini S: Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABA(A) receptor alpha 6 subunit. J Neurosci. 1996 Jun 1;16(11):3630-40. Pubmed
• Korpi ER, Kuner T, Seeburg PH, Luddens H: Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995 Feb;47(2):283-9. Pubmed
• Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ: Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Mol Pharmacol. 1996 Sep;50(3):670-8. Pubmed